Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Journal Article (Journal Article)
The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.
Full Text
Duke Authors
Cited Authors
- Benson, AB; Venook, AP; Al-Hawary, MM; Cederquist, L; Chen, Y-J; Ciombor, KK; Cohen, S; Cooper, HS; Deming, D; Engstrom, PF; Grem, JL; Grothey, A; Hochster, HS; Hoffe, S; Hunt, S; Kamel, A; Kirilcuk, N; Krishnamurthi, S; Messersmith, WA; Meyerhardt, J; Mulcahy, MF; Murphy, JD; Nurkin, S; Saltz, L; Sharma, S; Shibata, D; Skibber, JM; Sofocleous, CT; Stoffel, EM; Stotsky-Himelfarb, E; Willett, CG; Wuthrick, E; Gregory, KM; Freedman-Cass, DA
Published Date
- July 2018
Published In
Volume / Issue
- 16 / 7
Start / End Page
- 852 - 871
PubMed ID
- 30006428
Electronic International Standard Serial Number (EISSN)
- 1540-1413
Digital Object Identifier (DOI)
- 10.6004/jnccn.2018.0060
Language
- eng
Conference Location
- United States